Analgesic Nephropathy
Analgesic nephropathy, a type of chronic interstitial nephritis, was originally described in conjunction with overuse of combination analgesics containing phenacetin (typically with aspirin, acetaminophen, codeine, or caffeine). However, despite removal of phenacetin from the market, analgesic nephropathy continued to occur. Studies to identify the causal agent are equivocal, but acetaminophen, aspirin, and other NSAIDs have been implicated. Mechanism is unclear. Whether COX-2 inhibitors cause analgesic nephropathy is not known, but these drugs probably can cause acute tubulointerstitial nephritis and nephrotic syndrome due to minimal change disease or membranous nephropathy.
Analgesic nephropathy predominates in women (peak incidence, 50 to 55 yr) and, in the US, is responsible for 3 to 5% of cases of end-stage renal disease (13 to 20% in Australia and South Africa).